0 results found with selected filters. Please refine the filters. Redirecting to initial search..
Table "column sort" updates the order of the bars in the chart.
downloaded on: 2023/03/25 18:25:22
Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Value |
Units |
SEM |
SD |
Method |
Method Duration |
Post Insult Time Value |
Record ID |
Study ID |
LH/Mav |
renal blood flow rate to kidney weight ratio |
vehicle control condition then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
renal blood flow trait |
male |
84 days
| 8 |
5.0 |
ml/min/g |
0.3 |
0.85 |
ultrasonic flowmeter |
0.0 |
0 |
102853 |
2761 |
LH/Mav |
renal blood flow rate to kidney weight ratio |
hydralazine (75 mg/kg/d) (for 63 days) and controlled hydralazine content drinking water (15 mg/kg/d) (for 63 days) and reserpine (0.75 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
renal blood flow trait |
male |
84 days
| 10 |
4.7 |
ml/min/g |
0.3 |
0.95 |
ultrasonic flowmeter |
0.0 |
0 |
102856 |
2761 |
LH/Mav |
renal blood flow rate to kidney weight ratio |
perindopril (1.5 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
renal blood flow trait |
male |
84 days
| 7 |
5.3 |
ml/min/g |
0.5 |
1.32 |
ultrasonic flowmeter |
0.0 |
0 |
102854 |
2761 |
LH/Mav |
renal blood flow rate to kidney weight ratio |
nifedipine (50 mg/kg/d) (for 63 days) then ketamine (20 mg/kg) and thiobutabarbital (75 mg/kg) |
Issiakhem M, et al., J Cardiovasc Pharmacol. 2008 Mar;51(3):280-5. doi: 10.1097/FJC.0b013e31816299a5. |
renal blood flow trait |
male |
84 days
| 7 |
4.9 |
ml/min/g |
0.5 |
1.32 |
ultrasonic flowmeter |
0.0 |
0 |
102855 |
2761 |
|